IMACLA Trademark

Trademark Overview


On Thursday, March 31, 2011, a trademark application was filed for IMACLA with the United States Patent and Trademark Office. The USPTO has given the IMACLA trademark a serial number of 85282897. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 10, 2014. This trademark is owned by Eli Lilly and Company. The IMACLA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antidepressants
imacla

General Information


Serial Number85282897
Word MarkIMACLA
Filing DateThursday, March 31, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 10, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 9, 2011

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antidepressants
Translation of Words in MarkThe wording IMACLA has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 5, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, November 10, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 10, 2014ABANDONMENT - NO USE STATEMENT FILED
Saturday, March 8, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 7, 2014EXTENSION 5 GRANTED
Friday, February 28, 2014EXTENSION 5 FILED
Friday, February 28, 2014TEAS EXTENSION RECEIVED
Friday, August 30, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 29, 2013EXTENSION 4 GRANTED
Tuesday, August 27, 2013EXTENSION 4 FILED
Tuesday, August 27, 2013TEAS EXTENSION RECEIVED
Thursday, March 7, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 6, 2013EXTENSION 3 GRANTED
Monday, March 4, 2013EXTENSION 3 FILED
Monday, March 4, 2013TEAS EXTENSION RECEIVED
Wednesday, September 5, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 4, 2012EXTENSION 2 GRANTED
Thursday, August 30, 2012EXTENSION 2 FILED
Thursday, August 30, 2012TEAS EXTENSION RECEIVED
Wednesday, March 21, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 20, 2012EXTENSION 1 GRANTED
Friday, February 24, 2012EXTENSION 1 FILED
Monday, March 19, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, February 24, 2012TEAS EXTENSION RECEIVED
Tuesday, October 4, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 9, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 9, 2011PUBLISHED FOR OPPOSITION
Monday, June 27, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 27, 2011ASSIGNED TO EXAMINER
Tuesday, April 5, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 4, 2011NEW APPLICATION ENTERED IN TRAM